Potassium Bicarbonate
Also known as: KHCO3, potassium hydrogen carbonate
Randomised trials in older adults show that oral potassium bicarbonate at doses studied (1–1.5 mmol/kg/day) reduced urinary nitrogen excretion relative to intake over 84 days, suggesting a muscle‑sparing effect. A long-term trial in postmenopausal women analysed relations between urinary potential renal acid load and mean arterial pressure while participants received potassium bicarbonate or placebo, finding associations between diet-dependent acid load and MAP that were stronger in normotensive participants.
Last reviewed: 2026-10-14 · 2 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Potassium bicarbonate is an alkaline potassium salt used to neutralise dietary acid load and as a source of potassium. In trials it has been tested orally for effects on acid-base balance, urinary nitrogen excretion and associations with blood pressure.
Mechanism & Function
Mechanism of Action
Provides alkali to neutralise dietary acid, shifting systemic acid-base balance towards less acidity; supplies potassium which can alter renal handling of sodium and influence potassium-driven effects on muscle protein metabolism and blood pressure regulation.
Physiological Role
Modulates systemic acid-base status, contributes to potassium homeostasis and renal electrolyte handling, and may reduce muscle protein breakdown as reflected by lower urinary nitrogen excretion relative to intake.
Primary Pathways
Performance / Health Relevance
By neutralising dietary acid load, potassium bicarbonate may reduce muscle-protein breakdown in older adults under free-living conditions, which could be relevant for preservation of lean mass; effects on blood pressure appear to be linked to changes in dietary acid load and may be more evident in normotensive people.
Evidence Review
No meta-analyses or systematic reviews indexed for this ingredient yet.
Dimensions marked N/A have no indexed evidence of that class. They are shown as unavailable rather than scored.
Compare Potassium Forms
Full comparison6 potassium forms are indexed. Bioavailability, clinical evidence, and best-use cases differ meaningfully between them.
| Form | Evidence |
|---|---|
Potassium BicarbonateThis page Potassium salts are generally well absorbed orally. | 53/100 |
| Potassium Citrate Highly bioavailable when dissolved. | 68/100 |
| Dietary Nitrate (Potassium Nitrate) Enterosalivary reduction (oral bacteria) is required for bioconversion to nitrite; use of antibacterial mouthwash can blunt the effect | 67/100 |
| Iodine Iodide salts and iodised oil were used in trials; urinary iodine increases reliably after supplementation. | 59/100 |
| Dipotassium Phosphate High intestinal absorption. | 58/100 |
| Potassium Chloride Oral potassium chloride increases urinary potassium excretion; slow‑release formulations were used in multiple trials | 55/100 |
Practical Use & Dosage
- Minimum Effective Dose
- 1 mmol/kg/day (as used in RCT low dose)
- Optimal Range
- 1–1.5 mmol/kg/day (doses tested in RCTs)
- Upper / Caution Level
- Not established from the provided abstracts
- Timing
- Oral dosing throughout the day as used in trials (no specific timing reported)
- Best Format
- Oral tablet or powder
- Bioavailability
- Potassium salts are generally well absorbed orally.
- Absorption Considerations
- Requires monitoring in people with impaired renal function because of risk of hyperkalaemia; co-administration with other potassium sources increases total potassium exposure.
Safety & Interactions
Side Effects
- •Gastrointestinal upset (reported with oral potassium salts in general literature)
- •Hyperkalaemia (risk especially with renal impairment or concomitant potassium-raising drugs)
- •Metabolic alkalosis if excessive alkali load
Contraindications
- Significant renal impairment
- Baseline hyperkalaemia
Drug Interactions
- •Potassium-sparing diuretics (e.g. spironolactone)
- •ACE inhibitors and ARBs
- •NSAIDs (may impair renal potassium excretion)
Who Should Avoid
- •People with chronic kidney disease
- •Those with baseline hyperkalaemia
- •People on multiple drugs that raise serum potassium
Monitoring
Monitor serum potassium and renal function when used chronically or in people with potential renal impairment or taking interacting medications.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Potassium Bicarbonate typically used or indicated?
Potassium Bicarbonate is most commonly used for: Neutralise dietary acid load, Maintain potassium levels, Support muscle protein retention in older adults, Antacid ingredient in alginate reflux formulations. Modulates systemic acid-base status, contributes to potassium homeostasis and renal electrolyte handling, and may reduce muscle protein breakdown as reflected by lower urinary nitrogen excretion relative to intake.
How does Potassium Bicarbonate work?
Provides alkali to neutralise dietary acid, shifting systemic acid-base balance towards less acidity; supplies potassium which can alter renal handling of sodium and influence potassium-driven effects on muscle protein metabolism and blood pressure regulation.
What is the recommended dose of Potassium Bicarbonate?
The optimal range is 1–1.5 mmol/kg/day (doses tested in RCTs). with a minimum effective dose of 1 mmol/kg/day (as used in RCT low dose). Best taken: Oral dosing throughout the day as used in trials (no specific timing reported). Upper / caution level: Not established from the provided abstracts.
What are the side effects of Potassium Bicarbonate?
Reported side effects include: Gastrointestinal upset (reported with oral potassium salts in general literature); Hyperkalaemia (risk especially with renal impairment or concomitant potassium-raising drugs); and Metabolic alkalosis if excessive alkali load. Monitoring: Monitor serum potassium and renal function when used chronically or in people with potential renal impairment or taking interacting medications.
Does Potassium Bicarbonate interact with medications?
Known or theoretical interactions: Potassium-sparing diuretics (e.g. spironolactone); ACE inhibitors and ARBs; and NSAIDs (may impair renal potassium excretion). Always check with a clinician before combining with prescription medication.
Who should avoid Potassium Bicarbonate?
Potassium Bicarbonate is generally not recommended for: People with chronic kidney disease; Those with baseline hyperkalaemia; People on multiple drugs that raise serum potassium; Significant renal impairment; and Baseline hyperkalaemia.
How strong is the evidence for Potassium Bicarbonate?
Evidence level: Limited (overall score 53/100), based on 2 indexed studies on SuppIndex.
Research & References (2)
Increasing alkali supplementation decreases urinary nitrogen excretion when adjusted for same day nitrogen intake.
Randomised placebo-controlled trial in older men and women that compared escalating doses of oral potassium bicarbonate (1 mmol/kg/day and 1.5 mmol/kg/day) versus placebo over 84 days, assessing urinary nitrogen excretion adjusted for same-day nitrogen intake as a marker of muscle protein breakdown.
Diet-dependent acid load is associated with mean arterial pressure in a cohort of non-obese, non-black, postmenopausal women.
Randomised trial of potassium bicarbonate versus placebo over 36 months in postmenopausal women, with analyses relating urinary potential renal acid load (UPRAL) and sodium changes to mean arterial pressure (MAP).
Related Ingredients
Other top-rated ingredients in Minerals.
Magnesium Glycinate
84/100An amino acid chelate of magnesium providing elemental Mg²⁺ bound to two glycine molecules, offering superior bioavailability and minimal gastrointestinal side effects.
Calcium Citrate
75/100Calcium bound to citric acid; ~24% elemental Ca by mass; absorbed across the small intestine via active transport and paracellular diffusion regardless of gastric pH.
Zinc
74/100Systematic reviews and meta-analyses of human trials show that oral zinc supplementation reduces duration and increases recovery rates in acute and persistent watery diarrhoea in children; lowers inflammatory lesion counts in acne; reduces pain severity in primary dysmenorrhea; and in small trials (20–30 mg/day) improved fasting glucose and 2‑hr OGTT in people with prediabetes. Adverse effects reported include increased vomiting in children receiving zinc for diarrhoea.
Research Overview
Limited EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/potassium-bicarbonate
SuppIndex. (2026). Potassium Bicarbonate: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/potassium-bicarbonate
Based on 2 indexed studies · Evidence level: Limited.
Goal Ratings
Stack Compatibility
Combining with other potassium-containing supplements or salt substitutes increases hyperkalaemia risk; co-use with sodium-reducing strategies may be reasonable but monitor electrolytes.